Advanced Breast Cancer: Patritumab Deruxtecan Study

We are testing a new drug for patients with advanced breast cancer to see how well it works. The study will also analyze biomarkers to understand treatment responses better.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Hopital Tenon
ONCOLOGIE
Bagnolet, France
Institut Regional Du Cancer De Montpellier
ONCOLOGIE
Grabels, France
Centre Hospitalier Et Universitaire De Limoges
ONCOLOGIE
Isle, France

Sponsor: Institut Gustave Roussy
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.